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Abstract
Recent studies have implicated epigenetics in the pathophysiology of diabetes. Further-
more, DNA methylation, which irreversibly deactivates gene transcription, of the insulin pro-
moter, particularly the cAMP response element, is increased in diabetes patients. However,
the underlying mechanism remains unclear. We aimed to investigate insulin promoter DNA
methylation in an over-nutrition state. INS-1 cells, the rat pancreatic beta cell line, were cul-
tured under normal-culture-glucose (11.2 mmol/l) or experimental-high-glucose (22.4 mmol/l)
conditions for 14 days, with or without 0.4 mmol/l palmitate. DNAmethylation of the rat insulin
1 gene (Ins1) promoter was investigated using bisulfite sequencing and pyrosequencing anal-
ysis. Experimental-high-glucose conditions significantly suppressed insulin mRNA and in-
creased DNAmethylation at all five CpG sites within the Ins1 promoter, including the cAMP
response element, in a time-dependent and glucose concentration-dependent manner. DNA
methylation under experimental-high-glucose conditions was unique to the Ins1 promoter;
however, palmitate did not affect DNAmethylation. Artificial methylation of Ins1 promoter sig-
nificantly suppressed promoter-driven luciferase activity, and a DNAmethylation inhibitor sig-
nificantly improved insulin mRNA suppression by experimental-high-glucose conditions.
Experimental-high-glucose conditions significantly increased DNAmethyltransferase activity
and decreased ten-eleven-translocation methylcytosine dioxygenase activity. Oxidative
stress and endoplasmic reticulum stress did not affect DNAmethylation of the Ins1 promoter.
High glucose but not palmitate increased ectopic triacylglycerol accumulation parallel to DNA
methylation. Metformin upregulated insulin gene expression and suppressed DNAmethyla-
tion and ectopic triacylglycerol accumulation. Finally, DNAmethylation of the Ins1 promoter
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increased in isolated islets from Zucker diabetic fatty rats. This study helps to clarify the effect
of an over-nutrition state on DNAmethylation of the Ins1 promoter in pancreatic beta cells. It
provides new insights into the irreversible pathophysiology of diabetes.
Introduction
Type 2 diabetes is an insulin insufficiency state caused by decreased pancreatic beta cell func-
tion and mass [1,2]. Genetic and environmental factors influence the development of type 2
diabetes, with the nutritional state being particularly important. In preclinical type 2 diabetes,
beta cells secrete excessive insulin and considerably expand their mass to compensate for the
increased metabolic load and obesity-associated insulin resistance. However, failure of beta cell
adaptation leads to type 2 diabetes onset with declining insulin secretion and beta cell mass [1].
Beta cell dysfunction then deteriorates, particularly in individuals with poor glycemic control,
and eventually becomes irreversible despite glucotoxicity treatments providing temporary im-
provements in the dysfunction to some extent [2].
When glycemic control is poor, it is widely accepted that the associated diabetic complica-
tions will worsen. Moreover, the Diabetes Control and Complications Trial/Epidemiology of
Diabetes Interventions and Complications and United Kingdom Prospective Diabetes Study
showed correlations between transient poor glycemic control and progression of diabetic com-
plications [3,4]. This “metabolic memory” or “legacy effect” phenomenon is partially regulated
by epigenetic modification, which causes histone 3 lysine 4 monomethylation in aortic endo-
thelial cells under transient high-glucose states and sustains the high inflammatory cytokine
levels under subsequent normoglycemia [5–7].
Epigenetic modification regulates gene expression without altering the DNA sequence and
mainly occurs through histone modification and DNAmethylation [8]. Histone modifications
usually control the chromatin structure and transcriptional activity and include methylation,
acetylation, phosphorylation, sumoylation, and ubiquitination at histone N-terminals [9].
DNAmethylation occurs at the cytosine site in the CpG dinucleotide where it irreversibly deac-
tivates gene transcription and is balanced by the effects of DNA methyltransferase (DNMT)
and ten-eleven-translocation methylcytosine dioxygenase (TET) [10]. DNAmethylation re-
presses transcriptional activity, either by directly preventing transcriptional factors from bind-
ing to their cognate sequences or by recruiting transcriptional repressor complexes that form
heterochromatin (“closed,” or inactive, chromatin) [11].
Recent studies have reported that epigenetic modulation of beta cells could be of pathogenic
importance in type 2 diabetes. A genome-wide DNA methylation analysis identified different
DNAmethylation patterns on candidate genes in the islets of patients with type 2 diabetes. In
that study, 17 of 40 type 2 diabetes candidate genes were differently methylated, e.g. potassium
voltage-gated channel KQT-like subfamily member 1 (KCNQ1) and transcription factor 7-like
2 (TCF7L2). Moreover, functional analysis demonstrated that cyclin-dependent kinase inhibi-
tor 1A (CDKN1A) and phosphodiesterase 7B (PDE7B), which exhibit decreased DNAmethyla-
tion and increased gene expression in type 2 diabetes, result in impaired insulin secretion and
exocyst complex component 3-like 2 (EXOC3L2), which exhibits increased DNAmethylation
and decreased gene expression in type 2 diabetes, results in decreased exocytosis from pancre-
atic beta cells [12]. DNAmethylation of the pancreatic and duodenal homeobox factor-1
(Pdx1) promoter of intrauterine growth retardation rats is considered a major cause of suscep-
tibility to glucose intolerance in adulthood [13]. A recent study involving patients with type 2
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diabetes showed that elevated DNAmethylation of the insulin gene promoter, particularly at
the cAMP response element (CRE) site, was proportional to HbA1c levels and inversely propor-
tional to insulin gene expression [12,14]. However, the precise mechanism underlying DNA
methylation in the diabetic state remains unclear.
We hypothesized that long-term environmental exposure to high glucose levels would cause
epigenetic modification and irreversible damage to beta cells. This study aimed to elucidate the
effects of an over-nutrition state on epigenetic modification in the insulin gene promoter. In
particular, we investigated the role of the high glucose state on DNAmethylation of the CpG
site in the insulin gene promoter.
Materials and Methods
Materials
Sodium palmitate, forskolin, 3-isobutyl-1-methylxanthine (IBMX), 5-Aza-20-deoxycytidine
(DAC), and N-acetyl-cysteine were obtained from Sigma (St Louis, MO, USA). Metformin was
obtained from Enzo Life Sciences (Farmingdale, NY, USA). Hydrogen peroxide (H2O2) was
obtained from Santoku Chemical Industries (Tokyo, Japan). Thapsigargin and taurourso-
deoxycholic acid (TUDCA) were obtained from Calbiochem (La Jolla, CA, USA). The insulin
enzyme-linked immunosorbent assay (ELISA) kit was obtained fromMorinaga (Tokyo,
Japan), and the triglyceride quantification colorimetric/fluorometric kit was obtained from
BioVision (Milpitas, CA, USA). EpiQuik DNMT activity/inhibition assay and Epigenase
5 mC-Hydroxylase TET activity/inhibition assay kits were obtained from Epigentek (Farming-
dale, NY, USA). The Cell Proliferation Kit I (MTT assay) was obtained from Roche Applied
Science (Branford, CT, USA).
Cell culture
The pancreatic beta cell line (INS-1 cells) were provided by Dr. CBWollheim (University of
Geneva, Geneva, Switzerland) [15]. They were cultured in RPMI1640 media supplemented
with 10% fetal bovine serum (FBS), 2 μl/500 ml beta-mercaptoethanol, and antibiotics
(100 units/ml penicillin–100 μg/ml streptomycin). Cells were maintained at 37°C in a humidi-
fied atmosphere containing 95% air and 5% CO2. Cells were passaged by trypsinization and
were subcultured every fourth day. Cells (passage: 45–70) were cultured under the conditions
indicated for each experiment.
Palmitate was precomplexed to FFA-free bovine serum albumin (BSA) (Wako Pure Chemi-
cal Industries, Japan) at a 2:1 (palmitate:BSA) molar ratio. Control cells were incubated with
media containing FFA-free BSA at the same concentration as palmitate-exposed cells.
Animals
Male Zucker diabetic fatty rats (ZDF rats; Charles River Laboratories, Wilmington, MA, USA),
a diabetes-prone model due to a mutated leptin receptor, were maintained in a 12-h light/dark
cycle with free access to water and food (Purina Diet 5008, Charles River Laboratories). All re-
search procedures involving animals were performed in accordance with the Laboratory Ani-
mals Welfare Act, the Guide for the Care and Use of Laboratory Animals, and the Guidelines
and Policies for Rodent Experiments provided by the Institutional Animal Care and Use Com-
mittee at the Nagoya University Graduate School of Medicine and were reviewed and approved
by the Institutional Animal Care and Use Committee. The protocol was approved by the com-
mittee on the Ethics of Animal experiments of the Nagoya University Graduate School of Med-
icine (Permit Number: 26060). All surgeries were performed under sodium pentobarbital
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anesthesia, and reasonable efforts were made to minimize suffering. Rats were sacrificed by
intraperitoneal administration of sodium pentobarbital (200 mg/kg).
Real-time polymerase chain reaction (PCR)
Total RNA was extracted from INS-1 cells using the RNeasy Plus Mini kit from Qiagen (Valen-
cia, CA, USA). Target gene mRNA expression relative to phosphatidylinositol 3-kinase (Pi3k)
p85 was quantified using the Power SYBR Green RNA-to-CT 1-Step kit in the 7300 Real-Time
PCR System (Applied Biosystems, Foster City, CA, USA). The sequences of the specific primer
pairs are described in S1 Table.
Pyrosequencing analysis
Nucleotide sequences for the rat Ins1 gene (Gene ID: 24505) and insulin receptor substrate
2 (Irs2) gene (Gene ID: 29376) were obtained from GenBank. Genomic DNA was extracted
from INS-1 cells and rat pancreatic islets using the DNeasy tissue kit (Qiagen). Extracted DNA
(2 μg) was then subjected to bisulfite conversion using the EpiTect Bisulfite kit (Qiagen). Bisul-
fite-treated DNA (1 μl) was amplified by the universal primer approach in 50 μl reaction mix-
ture containing primers and 0.2 U rTaq polymerase from Takara (Otsu, Japan) [16]. Primers
for pyrosequencing analysis were designed using Pyrosequencing Assay Design software (Bio-
tage, Westborough, MA, USA). The biotinylated PCR products by universal primer approach
were immobilized with streptavidin-coated Sepharose beads, purified, and then denatured
using a 0.2 mol/l NaOH solution. The purified single-stranded PCR products were annealed to
0.3 μmol/l pyrosequencing primers, and pyrosequencing was performed on Biotage’s PSQ
96 MA Pyrosequencing System. Following this, the methylation rate was calculated using
Qiagen’s PyroMark CpG software. The primer sequences for pyrosequencing analysis and PCR
are described in S2 Table.
Bisulfite sequencing analysis
The rat Ins1 gene was amplified with pairs of gene-specific primers (S3 Table) in a mixture
containing bisulfite-treated DNA (100 ng). PCR was performed using TaKaRa EpiTaq HS
(Takara). The bisulfite-PCR product of the rat Ins1 promoter was cloned into the pGEM-T
Easy Vector (Promega, Madison, WI, USA) and sequenced with a T7 primer (Takara Dragon
Genomics Center, Mie, Japan). At least 30 clones were sequenced per sample.
Luciferase assay
INS-1 cells were transfected with a pGL4.10 [luc2] vector containing rat Ins1 469 - base pair
(bp) promoter and pGL4.74 [hRluc/TK] vector using the FuGENE HD reagent (Promega)
according to the manufacturer’s protocol. The pGL4.10 [luc2] vector (Promega, Madison, WI)
was digested with BglII/HindIII and treated with alkaline phosphatase (CIP) (New England
BioLabs, Ipswich, MA). A fragment of the rat Ins1 promoter (−304 to +192 bp containing five
CpG sites) was amplified by PCR using genomic DNA and primers that added BglII and
HindIII sites to the ends. PCR products were inserted into the pGEM-T Easy Vector (Promega)
and amplified in SOC medium (super optimal broth with catabolite repression). The plasmid
sequences were confirmed by DNA sequencing. The cloned promoter fragments were excised
and subcloned upstream of the firefly luciferase gene in the pGL4.10 [luc2] vector using T4
DNA Ligase (Promega) according to the manufacturer’s recommendation and transformed
into DH5α competent cells (Promega) for plasmid production. The pGL4.10 [luc2] vector con-
taining the rat Ins1 469-bp promoter was either methylated using 10 U of M.SssI CpG
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methyltransferase (New England BioLabs) or mock-methylated in a parallel control reaction
without the enzyme. Luciferase activity was measured 48 h after transfection. Firefly and
Renilla luciferase activities in cell lysates were measured using the Dual-Luciferase Reporter
Assay System (Promega) in a Lumat LB 9507 luminometer (Berthold Technologies, Bad
Wildbad, Germany) according to the manufacturer’s instruction. Firefly luminescence was
normalized by the Renilla luminescence.
Glucose-stimulated insulin secretion (GSIS)
INS-1 cells were preincubated with 2.8 mmol/l Krebs–Ringer buffer (KRB) buffer for 30 min
and stimulated with 16.7 mmol/l glucose for 30 min. We measured supernatant as release and
acid–ethanol extract as content. Release and content were measured using H.T.R.F (Cisbio Bio-
assays, France). The amount of insulin secreted was normalized by cellular insulin contents.
Pancreatic islet isolation
Pancreatic islets were isolated from 12-week-old ZDF rats by collagenase digestion, as de-
scribed previously [17].
Measurement of the insulin content of isolated islet
The total pancreatic insulin content was measured according to a standard acid–ethanol
extraction protocol. The islet insulin was measured using H.T.R.F. The amount of insulin se-
creted was normalized by pancreatic weight.
Immunofluorescence staining
For morphometric analysis, pancreatic islets were isolated from 12-week-old male ZDF rats.
The pancreas was fixed in 4% paraformaldehyde and sequentially washed thoroughly in phos-
phate-buffered saline containing 10% and 20% sucrose. They were then embedded in OCT
Compound (Sakura Finetek, Tokyo, Japan) and frozen. Serial 10-μm sections were cut at
100-μm intervals, and five sections were randomly selected from each pancreas. The sections
were incubated overnight with polyclonal anti-insulin guinea pig antibody and polyclonal anti-
glucagon rabbit antibody (1:500) from Abcam (Tokyo, Japan) at 4°C. After washing with
phosphate-buffered saline, they were incubated for 1 h in a mixture of rhodamine-conjugated
anti-guinea pig and anti-rabbit immunoglobulin G antibody before being incubated with
40,6-diamidino-2-phenylindole (DAPI) solution (1:2000; Dojindo (Tokyo, Japan) for 20 min.
The sections were analyzed using the BZ-9000 Fluorescent Microscope System from Keyence
(Osaka, Japan). The ratio of glucagon-positive cells to insulin-positive cells was calculated
using the HS BZ-II analysis application (Keyence). In total, 90 islets from three rats were esti-
mated per group.
Statistical analysis
Data are expressed as mean ± standard error along with experiment numbers. Differences be-
tween the means of the two groups were compared by unpaired two-tailed Student t test
(Microsoft Excel 2010). Comparison of quantitative variables among groups were performed
using analysis of variance (ANOVA) with the Tukey post-hoc test via GraphPad Prism (v.6.03;
GraphPad Software, San Diego, CA, USA). We considered p values 0.05 to be
statistically significant.
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Results
Glucotoxicity and DNAmethylation of the CpG site at CRE in the Ins1
promoter
Insulin transcription is mainly regulated by the promoter region located approximately 400
nucleotides upstream of the transcription start site [18]. Both rat insulin 1 (Ins1) and insulin
2 (Ins2) genes have one CRE site in their promoters. The CRE site in the Ins1 promoter but not
in the Ins2 promoter has a CpG dinucleotide sequence susceptible to DNA methylation [19]
(S1 Fig.). Therefore, we examined the DNAmethylation of the CpG site at CRE in the Ins1 pro-
moter (which we refer to as DNAmethylation of the Ins1 promoter) in an over-nutrition state.
INS-1 cells were cultured under either normal-culture-glucose (NG; 11.2 mmol/l) or 22.4
mmol/l experimental-high-glucose (HG) conditions for 14 days with or without 0.4 mmol/l
palmitate. Incubation under HG conditions, with and without 0.4 mmol/l palmitate, signifi-
cantly decreased insulin mRNA levels by 80%–95% compared with that under NG conditions
(p< 0.01). NG plus palmitate did not change insulin mRNA levels (Fig. 1A). Similarly, HG
with and without palmitate also markedly increased DNAmethylation of the Ins1 promoter,
although palmitate did not influence DNA methylation under NG conditions (NG, 4% ± 0.4%;
NG plus palmitate, 4.6% ± 0.4%; HG, 15.3% ± 0.8%; HG plus palmitate, 16.3% ± 0.4%; p<
0.01; Fig. 1B). Next, we evaluated DNAmethylation of the Irs2 gene, which has a CRE site in a
CpG island of its promoter [20] (S1 Fig.), to confirm whether the effect of HG conditions on
DNAmethylation was specific to the Ins1 promoter. None of the conditions affected either
DNAmethylation at the CRE site of the Irs2 promoter or Irs2mRNA levels (S2 Fig.).
Following this, we investigated the effect of glucose concentrations and incubation periods
on DNAmethylation of the Ins1 promoter in INS-1 cells. Insulin mRNA levels significantly de-
creased by 75%–85% under 16.7, 22.4, and 33.6 mmol/l glucose conditions (Fig. 1C), and DNA
methylation of the Ins1 promoter significantly increased compared with that under NG condi-
tions (6.3% ± 0.4%, 9.7% ± 1.1%, 12.7% ± 0.4%, and 2.7% ± 0.4%, respectively; Fig. 1D). Insulin
mRNA levels significantly decreased by 80%–90% at days 3, 7, and 14 (p< 0.01) (Fig. 1E), and
DNAmethylation of the Ins1 promoter significantly increased at days 7 and 14 under HG con-
ditions compared with that under NG conditions (day 3, 5.0% ± 0.7%; day 7, 7.3% ± 0.4%; day
14, 12.3% ± 0.4%; Fig. 1F). NG plus 0.8 mmol/l palmitate caused insulin mRNA levels to de-
cease by 55%, whereas DNA methylation of the Ins1 promoter did not increase (Fig. 1G and
1H). After 14 days of culture under 22.4 mmol/l HG or NG plus 0.8 mmol/l palmitate, GSIS of
these cells was significantly decreased.
These data show that long-term incubation in the HG state (glucotoxicity) rather than pal-
mitate toxicity is essential for DNAmethylation of the Ins1 promoter. In beta cells, DNAmeth-
ylation caused by HG was not global because no DNAmethylation occurred at the CRE site of
the Irs2 promoter under the HG state. DNA methylation by glucotoxicity was both time and
concentration dependent.
Gene transcription suppressed by DNAmethylation of the Ins1 promoter
In addition to the CpG site of CRE, the rat Ins1 promoter contains four other CpG sites (−171,
−113, −68, and +67) within a 500-bp region upstream of the ATG start codon. To confirm
whether long-term HG incubation specifically induced DNAmethylation at the CRE site of in-
terest, we evaluated DNA methylation at the other sites. Bisulfite sequencing analysis revealed
that long-term HG incubation induced DNAmethylation at all CpG sites within the rat Ins1
promoter (Fig. 2A).
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Because our insulin primer cannot distinguish between Ins1 and Ins2, we then examined
Ins1 promoter activity using a luciferase assay in the pGL4.10 vector with methylated or mock-
methylated Ins1 469-bp promoter sequences to estimate the direct relationship between the
DNAmethylation of the Ins1 promoter and gene transcription (Fig. 2B). As shown in Fig. 2C,
compared with the mock-methylated vector, the methylated rat Ins1 469-bp promoter sup-
pressed luciferase activity by 95% (p< 0.01). In the mock-methylated vector, luciferase activity
was increased approximately threefold by cAMP stimulation for 3 h with 1 μmol/l forskolin/
10 μmol/l IBMX (p< 0.01). Meanwhile, the response to cAMP stimulation in the methylated
vector completely disappeared (Fig. 2C).
Following this, the DNAmethylation inhibitor DAC was used to estimate the deleterious
effect of glucotoxicity on insulin gene expression via DNA methylation. INS-1 cells under
22.4 mmol/l HG conditions were treated with the indicated concentrations of DAC for the last
3 days of the 14-day incubation period (Fig. 2D). We found that 50 nmol/l DAC significantly
decreased DNAmethylation of the Ins1 promoter (p< 0.01) and improved insulin mRNA
suppression under HG conditions (p< 0.05) (Fig. 2D and 2E). These data suggest a direct rela-
tionship between DNA methylation of the Ins1 promoter and insulin gene transcription that is
induced by glucotoxicity.
Glucotoxicity increased DNMT activity and decreased TET activity
We evaluated the effect of glucotoxicity on DNA methylation through the DNA methylation
modulators DNMT and TET in INS-1 cells. DNMT exists in three isoforms; DNMT1 main-
tains the methylation pattern during cell replication and DNMT 3a and 3b lead to de novo
DNAmethylation. TET also exists in three isoforms, TET1, TET2, and TET3, and catalyzes de-
methylation depending on α-ketoglutarate (αKG) and iron (II) oxide. Compared with NG con-
ditions, significant increases in both Dnmt1mRNA levels (p< 0.05) and DNMT activity
(twofold increase; p< 0.05) were observed under 22.4 mmol/l HG conditions for 14 days
(Fig. 3A and 3B). Compared with NG conditions, Tet1, Tet2, and Tet3mRNA levels did not
change, but TET activity decreased by 50% under the same HG conditions (p< 0.05) (Fig. 3C
and 3D). These data suggest that glucotoxicity upregulates methylation mechanisms through
increased DNMT activity and downregulates demethylation mechanisms through decreased
TET activity.
Oxidative stress and endoplasmic reticulum (ER) stress
Next, we evaluated the effects of oxidative stress and ER stress, the putative mechanisms
through which glucotoxicity affects DNA methylation of the Ins1 promoter. Treatment of
INS-1 cells with 50 μmol/l H2O2 (an oxidative stress inducer) for 14 days significantly de-
creased insulin mRNA levels by 30% without changing DNAmethylation of the Ins1 promoter
(p< 0.05) (Fig. 4A and 4B). Treatment of INS-1 cells with 1 mmol/l N-acetyl-cysteine (an
Fig 1. Insulin mRNA levels and DNAmethylation of the Ins1 promoter in high-glucose conditions. (A–
D) INS-1 cells were cultured for 14 days. (E and F) under normal-culture-glucose (11.2 mmol/l; white bar) or
experimental-high-glucose (22.4 mmol/l; black bar) conditions. (G and H) INS-1 cells cultured in 11.2 mmol/l
glucose conditions with palmitate for 14 days. Insulin mRNA levels (A, C, E, and G) were examined by real-
time PCR analysis. DNAmethylation of the Ins1 promoter (B, D, F, and H) was examined by pyrosequencing
analysis. (I) INS-1 cells were cultured for 14 days under the indicated conditions. Following this, GSIS was
performed with low glucose (2.8 mmol/l; white bar) or high glucose (16.7 mmol/l; black bar) for 30 min. All
results are mean ± SEM (n 4). Asterisks indicate statistically significant differences (*p< 0.05, **p<
0.01).
doi:10.1371/journal.pone.0115350.g001
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Fig 2. The contribution of DNAmethylation of the Ins1 promoter. (A) INS-1 cells were cultured under
normal-culture-glucose (11.2 mmol/l; white bar) or experimental-high-glucose (22.4 mmol/l; black bar)
conditions for 14 days. DNAmethylation of the Ins1 promoter was examined by bisulfite sequencing analysis.
(B) A diagram of the 496-bp rat Ins1 promoter (position −304 to +191 bp relative to the transcription start site)
in luciferase reporter plasmids. The positions of CpG sites are represented by lollipop markers. (C)
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antioxidant agent) for 14 days influenced neither the decreased insulin mRNA nor the elevated
DNAmethylation induced by 22.4 mmol/l HG conditions (Fig. 4C and 4D).
Treatment of INS-1 cells with 10 nmol/l thapsigargin (an ER stress inducer) for 14 days sig-
nificantly decreased insulin mRNA levels by 45% without changing DNA methylation of the
Ins1 promoter (p< 0.05) (Fig. 4E and 4F). INS-1 cell treatment with 0.1 mmol/l TUDCA (a
chemical chaperone that improves protein-folding capacity) for 14 days influenced neither the
decreased insulin mRNA nor the elevated DNAmethylation of the Ins1 promoter induced
Methylated (black bar) or mock-methylated (white bar) rat Ins1 promoter-transfected INS-1 cells were
incubated at 5.6 mmol/l glucose with/without cAMP-increasing agents, 1 μmol/l forskolin and 10 μmol/l IBMX
(forskolin/IBMX), for 3 h. Luciferase activities are presented as relative expression compared with the mock-
methylated vectors without forskolin/IBMX stimulation. The inset shows a magnified image of the methylated
vector. (D and E) INS-1 cells were treated with 5-Aza-20-deoxycytidine (DAC) for the last 3 days of the 14-day
incubation under 22.4 mmol/l high glucose conditions, and the medium containing DAC was changed every
24 h. Insulin mRNA levels (D) were examined by real-time PCR. DNAmethylation of the Ins1 promoter (E)
was examined by pyrosequencing analysis. All results are mean ± SEM (n 4). Asterisks indicate
statistically significant differences (*p< 0.05, **p< 0.01).
doi:10.1371/journal.pone.0115350.g002
Fig 3. The effect of a high-glucose state on DNMT and TET in INS-1 cells. (A-D) INS-1 cells were cultured
under normal-culture-glucose (11.2 mmol/l; white bar) or experimental-high-glucose (22.4 mmol/l; black bar)
conditions for 14 days. The Dnmt (A) and Tet (C) mRNA levels were examined by real-time PCR. DNA
methyltransferase (DNMT) (B) and ten-eleven-translocation methylcytosine dioxygenase (TET) (D) activities
were examined by ELISA. All results are mean ± SEM (n 4). Asterisks indicate statistically significant
difference (*p< 0.05, **p< 0.01).
doi:10.1371/journal.pone.0115350.g003
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under 22.4 mmol/l HG conditions (Fig. 4G and 4H). Thus, neither oxidative stress nor ER
stress induced DNA methylation of the Ins1 promoter.
DNAmethylation of the Ins1 promoter and intracellular triacylglycerol
(TAG) under HG conditions and metformin treatment
Because neither isolated oxidative stress nor ER stress affected DNA methylation, we focused
on other mechanisms of glucotoxicity. Intracellular TAG accumulation was significantly in-
creased under 22.4 mmol/l HG conditions, with and without 0.4 mmol/l palmitate, compared
with that under NG conditions for 14 days in INS-1 cells (p< 0.05; Fig. 5A). Interestingly, in-
tracellular TAG accumulation and DNA methylation of the Ins1 promoter increased only
under HG conditions. In addition, it is known that AMP-activated protein kinase (AMPK) ac-
tivation ameliorates intracellular TAG accumulation. Therefore, we assessed the effect of met-
formin, which activates AMPK, on insulin mRNA levels and DNA methylation of the Ins1
promoter. Compared with the 22.4 mmol/l HG conditions alone, metformin significantly in-
creased insulin mRNA levels by 2.5-fold, ameliorated intracellular TAG accumulation, and de-
creased the DNAmethylation of the Ins1 promoter (HG: 15.3% ± 0.4%; HG plus metformin:
10.0% ± 0.7%) (Fig. 5B, 5C, 5D). These data indicate that metformin directly affects beta cells
and that it inhibits the glucotoxicity-induced insulin mRNA reduction and DNAmethylation
of the Ins1 promoter.
DNAmethylation of the Ins1 promoter of the pancreatic islets of ZDF rats
To confirm DNAmethylation of the Ins1 promoter under obese and diabetic in vivo condi-
tions, we examined pancreatic islets from 12-week-old ZDF rats. Casual blood glucose levels
increased from 8 weeks of age in ZDF homozygous (fa/fa) rats, their excessive insulin secretion
gradually decreased over time, and insulin content was much lower in pancreatic islets from
12-week-old ZDF homozygous (fa/fa) rats (S3 Fig.). Furthermore, at 12 weeks, compared with
nondiabetic, heterozygous (fa/+) rats, DNA methylation of the Ins1 promoter increased (fa/+,
56% ± 6.0%; fa/fa, 79.5% ± 1.5%; p< 0.01) (Fig. 6A). Immunohistochemistry revealed that the
alpha/beta cell ratio in islets was not significantly different between fa/fa and fa/+ individuals
(fa/+, 28.7%; fa/fa, 31.2%; Fig. 6B and 6C). This result supports our in vitro experiments in
INS-1 cells.
Discussion
Our results showed that long-term exposure of pancreatic beta cells to the HG state but not to
the high-fatty-acid state increased DNA methylation of the Ins1 promoter in both time-depen-
dent and concentration-dependent manners. To our knowledge, this is the first report to eluci-
date the effect of over-nutrition on DNA methylation of the Ins1 promoter in beta cells.
Insulin gene expression and insulin secretion decrease as type 2 diabetes progresses [21,22].
In this study, insulin mRNA levels were significantly suppressed by HG incubation, and the ac-
tual transcriptional activity of the insulin gene may have been suppressed to a lesser degree
Fig 4. Oxidative stress and endoplasmic reticulum (ER) stress did not induce DNAmethylation of Ins1
promoter. INS-1 cells were cultured for 14 days under the following conditions: (A and B) with H2O2 in 11.2
mmol/l glucose; (C and D) with N-acetyl-cysteine (NAC) in 22.4 mmol/l glucose; (E and F) with thapsigargin in
11.2 mmol/l glucose; and (G and H) with tauroursodeoxycholic acid (TUDCA) in 22.4 mmol/l glucose. Insulin
mRNA levels (A, C, E, and G) were examined by real-time PCR. DNAmethylation of the Ins1 promoter (B, D,
F, and H) was examined by pyrosequencing analysis. All results are means ± SEM (n 4). Asterisks indicate
statistically significant differences (*p< 0.05, **p< 0.01).
doi:10.1371/journal.pone.0115350.g004
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than insulin mRNA levels because the HG conditions prolong the half-life of insulin mRNA
[23]. Philippe et al. have shown that a 2-bp mutation (CG> TT) in CRE of rat Ins1 resulted in
a significant suppression of the gene promoter activity, indicating that the CRE site in the insu-
lin promoter is important for insulin gene transcription [24]. Moreover, Kuroda et al. reported
that DNA methylation of the CpG site in CRE of the mouse Ins2 promoter significantly sup-
pressed promoter activity by approximately 50% [25]. Our data revealed that HG conditions
resulted in DNA methylation of the CpG site within the Ins1 promoter and that methylation
suppressed the transcriptional activity of Ins1. This suggests that glucotoxicity causes DNA
methylation in pancreatic beta cells and that this epigenetic mechanism may be a cause of the
irreversible decline in insulin mRNA levels induced by glucotoxicity.
Although this study showed that glucotoxicity increased DNA methylation by approximate-
ly 10% in INS-1 cells and that DNAmethylation certainly suppressed the transcriptional activi-
ty in reporter assays, other glucotoxicity mechanisms should also be involved in the decline in
insulin gene expression. In particular, the decrease in insulin gene expression at day 3 was
probably caused by glucotoxicity but not DNAmethylation. For example, glucotoxicity is
thought to cause oxidative stress and ER stress. Oxidative stress suppresses insulin gene tran-
scription by PDX-1 translocation from the nucleus to the cytosol by activating the cJun N-ter-
minal kinase (JNK) pathway [26]. In addition, glucotoxicity reportedly damages the DNA
binding affinity of PDX-1 [27], implying that DNAmethylation is involved. The association
Fig 5. Metformin improved insulin mRNA levels, intracellular triacylglycerol (TAG) content, and DNA
methylation of Ins1 promoter. (A) INS-1 cells were cultured in glucose and palmitate for 14 days. (B-D) INS-
1 cells were cultured with metformin for 14 days. Intracellular TAG levels (A and D) were examined by ELISA,
insulin mRNA levels (B) were examined by real-time PCR, and DNAmethylation of the Ins1 promoter (C) was
examined by pyrosequencing. All results are means ± SEM (n 4). Asterisks indicate statistically significant
differences (*p< 0.05, **p< 0.01).
doi:10.1371/journal.pone.0115350.g005
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between DNAmethylation and oxidative stress has frequently been reported in cancer research
[28,29]; for example, oxidative stress leads to DNAmethylation of the glutathione S-transferase
pi 1 gene promoter by the recruitment of transcriptional repressor complexes, including
DNMTs, in prostate cancer [28]. However, a single oxidative stress load did not increase DNA
methylation in our study, suggesting that oxidative stress is either irrelevant to DNA methyla-
tion or that additional factors are required in beta cells. Meanwhile, ER stress is reported to in-
duce histone modification, such as histone H3 lysine 4 monomethylation in the monocyte
chemoattractant protein-1 gene promoter, by activation of histone methyltransferase SET7/9
[30]. However, direct induction of DNAmethylation by ER stress has not been reported, and
our data demonstrated that a single ER stress load did not increase DNAmethylation in
beta cells.
In this study, DAC increased the insulin gene expression; however, the amelioration was
only partial, especially compared to the level at NG. Although it was difficult to use a higher
concentration of DAC and for a longer period, the partial amelioration may be caused by the
decrease in DNA methylation. In addition, we assume that the accumulation of the partial
amelioration results in the mitigation of progressive pathophysiology of type 2 diabetes.
In this study, HG conditions for 14 days increased Dnmt1mRNA levels and DNMT activity
in beta cells. Our data are consistent with a previous report that showed that exposure to
16.7 mmol/l glucose for 3 days increased the Dnmt1mRNA level and DNA methylation in the
Pdx1 promoter in beta cells [31]. Metabolites from the methionine cycle, particularly the ratio
Fig 6. DNAmethylation of Ins1 promoter in pancreatic islets frommale Zucker diabetic fatty (ZDF)
rats. (A) DNAmethylation of the Ins1 promoter was examined by pyrosequencing analysis in the pancreatic
islets isolated from 12-week-old ZDF rats. (B) The alpha/beta cell ratio was calculated in islets isolated from
heterozygous and homozygous ZDF rats. (C) Isolated pancreases were immunostained for insulin (green),
glucagon (red), and DAPI (blue) in heterozygous and homozygous ZDF rats. Scale bars indicate 100 μm.
Results are mean ± SEM. A: n = 4 rats. B: n = 90 islets from 3 rats per group. Asterisks indicate statistically
significant differences (*p< 0.05, **p< 0.01).
doi:10.1371/journal.pone.0115350.g006
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of S-adenosylmethionine (SAM) to S-adenosyl homocysteine (SAH), and the expression of
DNMT are important in the formation of methylated DNA because SAM is a donor of methyl
groups for DNMTs [32]. It has been reported that in human hepatocellular carcinoma cell
lines, HG conditions significantly increased DNMT activity, the ratio of SAM to SAH, and
global DNAmethylation [33]. Besides, the level of SAM and global DNAmethylation have
been significantly increased in the livers of ZDF rats [34,35]. Our data support these data, dem-
onstrating elevated DNAmethylation levels in the beta cells of ZDF rats, which suggests that
altered methionine metabolism in HG conditions is involved in epigenetic changes through
DNMT activity regulation in beta cells. This study also demonstrated that HG conditions sup-
pressed TET activity without changing TetmRNA levels. The activity of TET is dependent on
the level of αKG, which is a cofactor in the demethylation of TET [36]. The activity of isocitrate
dehydrogenase, which converts isocitrate into αKG, is reportedly suppressed by interleukin-1β
[37], which is endogenously produced in beta cells during glucotoxicity [37,38]. Therefore, glu-
cotoxicity-induced interleukin-1β overproduction may be involved in the decline in αKG accu-
mulation and TET activity in beta cells. However, future investigation is required to elucidate
the association between epigenetic modifications and the metabolic status of the methionine
cycle and glucose in beta cells under long-term HG conditions.
Interestingly, the pattern of ectopic TAG accumulation in an over-nutrition state was very
similar to that of DNAmethylation in the beta cells. Continuous HG conditions resulted in ec-
topic TAG accumulation by altering the activity of lipogenic enzymes [39]. Metformin, which
activates AMPK, ameliorates ectopic TAG accumulation by inhibiting acetyl-CoA carboxylase
[40]. In this study, metformin decreased both ectopic TAG accumulation and DNAmethyla-
tion of the Ins1 promoter and increased insulin mRNA. Although the association between
DNAmethylation and ectopic TAG accumulation remains unclear, our data suggest that insu-
lin gene upregulation by metformin is implicated in any interaction.
The present study has some limitations. First, because we could not mimic the long-term
high glucose condition in Wistar rats using continuous glucose infusion or isolated islets, we
used rat insulinoma INS-1 cells for the analysis of DNA methylation; these cells are known to
have aberrant growth regulation and are different from primary cells. DNA methylation of the
Ins1 promoter was significantly increased in the islets of ZDF rats, and the rate of DNAmethyl-
ation was much higher in the rat islets than in the INS-1 cells. This difference may have been
due to the different period of high glucose load and the presence of nonbeta cells in pancreatic
islets, in which the CpG cites within the insulin promoter could have been completely methyl-
ated [25]. However, considering that the alpha/beta cell ratio was comparable between hetero-
zygous and homozygous ZDF rats in this study, the higher methylation rate in islets from
homozygotes certainly indicated elevated DNA methylation of the Ins1 promoter in beta cells.
Further investigation using diabetic animal models is required to clarify the mechanism of epi-
genetic modification in type 2 diabetes.
Second, we cannot deny the possibility that HG worked in favor of the survival of the group
containing the hypermethylated Ins1 promoter. Further investigations using more homoge-
neous cell lines are required.
Finally, we performed palmitate treatment in complete INS-1 medium containing 10% FBS
in the present study. Nevertheless, unsatured fatty acids present in the serum may mask the
palmitate effect under such high FBS conditions. We confirmed the increase in the expression
of ER stress markers such as binding immunoglobulin protein (Bip) and spliced X box-binding
protein-1 (Xbp-1) by real-time PCR (S4 Fig.) and found that GSIS was significantly impaired
(Fig. 1I) without changing cell viability (S4 Fig.), indicating that the palmitate treatment in this
study showed a certain level of lipotoxicity. However, considering the possibility of attenuated
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lipotoxicity under 10% FBS culture, it is difficult to conclude that lipotoxicity was not at all in-
volved in DNAmethylation.
In conclusion, the present study provides a novel insight into the impact of glucotoxicity on
beta cell epigenetics. Glucotoxicity but not lipotoxicity induced DNA methylation of the Ins1
promoter, indicating that the accumulation of DNAmethylation under prolonged HG condi-
tions is at least implicated in the irreversible pathophysiology of diabetes. Furthermore, early
treatment to normalize the glycemic profile is critical to prevent the progressive deterioration
of beta cells and later diabetic complications. In the future, epigenetic modification of beta cells
may represent a useful therapeutic target to prevent the progression of diabetes. Interestingly,
we also identified a potential novel effect of metformin on insulin gene expression through epi-
genetic modification. Further investigation is required to elucidate the mechanisms underlying
these epigenetic modifications in beta cells.
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results are means ± SEM (n 4). Asterisks indicate statistically significant difference (p<
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